Balkrishan Simba Gill
2021
In 2021, Balkrishan Simba Gill earned a total compensation of $4.2M as Chief Executive Officer at Evelo Biosciences, a 94% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,813 |
|---|---|
| Option Awards | $3,372,930 |
| Salary | $575,000 |
| Other | $509 |
| Total | $4,217,252 |
Gill received $3.4M in option awards, accounting for 80% of the total pay in 2021.
Gill also received $268.8K in non-equity incentive plan, $575K in salary and $509 in other compensation.
Rankings
In 2021, Balkrishan Simba Gill's compensation ranked 3,166th out of 12,415 executives tracked by ExecPay. In other words, Gill earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,166 out of 12,415 | 75th |
Division Manufacturing | 1,277 out of 5,508 | 77th |
Major group Chemicals And Allied Products | 522 out of 2,378 | 78th |
Industry group Drugs | 463 out of 2,099 | 78th |
Industry Pharmaceutical Preparations | 320 out of 1,549 | 79th |
Source: SEC filing on April 26, 2022.
Gill's colleagues
We found two more compensation records of executives who worked with Balkrishan Simba Gill at Evelo Biosciences in 2021.
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019